Securities code: Heren Health Co.Ltd(300550) securities abbreviation: Heren Health Co.Ltd(300550) Announcement No.: 2022027 Heren Health Co.Ltd(300550)
Announcement of resolutions of the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Important tips
1. The shareholders’ meeting did not veto the proposal.
2. This general meeting of shareholders does not involve changing the resolutions adopted by previous general meetings of shareholders.
1、 Meetings held
1. Meeting time:
(1) On site meeting time: 15:00 PM, Wednesday, May 18, 2022
(2) Online voting time: May 18, 2022
The specific time of online voting through the trading system of Shenzhen stock exchange is: trading time on May 18, 2022, i.e. 9:15-9:25, 9:30-11:30 and 13:00-15:00; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 on May 18, 2022 to 15:00 on May 18, 2022.
2. Venue: conference room, 3rd floor, Heren Health Co.Ltd(300550) building, No. 625, Xinlian Road, Binjiang District, Hangzhou
3. Convening method: this general meeting of shareholders adopts the combination of on-site voting and online voting. Shareholders of the company should choose one of on-site voting and online voting. In case of repeated voting for the same voting right, the first voting result shall prevail.
4. Convener: Heren Health Co.Ltd(300550) board of directors
5. Moderator: Mr. Yang Yibing, chairman
6. Equity registration date: May 13, 2022
7. The convening, convening and voting procedures of this general meeting of shareholders comply with the provisions of laws, regulations and normative documents such as the company law, the rules for the general meeting of shareholders of listed companies, the Listing Rules of gem shares of Shenzhen Stock Exchange and the articles of association.
2、 Attendance at the meeting
Three shareholders and their authorized representatives attended the meeting, holding 130695914 shares in total, accounting for 493405% of the total shares of the company.
(1) Attendance at site meetings
There were 2 Shareholders and authorized representatives of shareholders attending the meeting, and the number of voting shares represented was 130695780 shares, accounting for 493404% of the total voting shares of the company.
(2) Shareholders’ participation through online voting
A total of one shareholder voted through the trading system and Internet voting system of Shenzhen Stock Exchange, representing 134 voting shares, accounting for 0.0001% of the total voting shares of the company.
(3) Information of minority shareholders participating in voting (other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company)
A total of 1 minority shareholder and authorized representative of shareholders participated in the voting at the general meeting of shareholders, representing 134 shares with voting rights, accounting for 0.0001% of the total voting shares of the company.
All directors and supervisors of the company attended the meeting, all senior managers attended the meeting as nonvoting delegates, and lawyers of Zhejiang Tiance law firm witnessed the meeting.
3、 Consideration and voting of proposals
The general meeting of shareholders considered and adopted the following proposals by combining on-site open voting and online voting:
(1) Deliberating the proposal on the work report of the board of directors in 2021
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(2) Review the proposal on the work report of the board of supervisors in 2021
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Waiver 0
(3) Deliberating the proposal on financial report of 2021
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(4) Deliberating the proposal on the financial final accounts report of 2021
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(5) Deliberating the proposal on the profit distribution plan for 2021
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
This proposal is a special resolution, which is approved by more than two-thirds of the valid votes held by the shareholders attending the meeting.
(6) Deliberating the proposal on the renewal of the company’s 2022 financial audit institution
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Waiver 0
(7) Deliberating the proposal on the remuneration scheme of directors, supervisors and senior managers in 2022, the voting results: 130695780 shares were agreed, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(8) Review the proposal on the full text and summary of the company’s 2021 Annual Report
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(9) Deliberating the proposal on applying for comprehensive credit from banks
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(10) Deliberating the proposal on using idle self owned funds to purchase financial products
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting; 134 opposed shares, accounting for 0.0001% of the shares held by all shareholders attending the meeting; Abstain 0 shares.
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
(11) Deliberating the proposal on using idle raised funds for cash management
Voting results: 130695780 shares were approved, accounting for 999999% of the shares held by all shareholders attending the meeting;
Among them, the voting situation of small and medium-sized investors (except the directors, supervisors, senior managers of the company and other shareholders who individually or jointly hold more than 5% of the shares of the company):
Agree to 0 shares; 134 opposed shares, accounting for 100.00% of the shares held by minority shareholders attending the meeting; Abstain 0 shares.
The independent directors of the company made an annual report at the general meeting of shareholders.
4、 Legal opinions issued by lawyers
The lawyer of Zhejiang Tiance law firm came to the meeting to certify the general meeting of shareholders and issued a legal opinion, holding that: Heren Health Co.Ltd(300550) the convening and convening procedures of the general meeting of shareholders, the qualifications of the attendees and conveners, and the voting procedures of the meeting are in line with the provisions of laws, regulations and the articles of association of the company; The voting result is legal and valid. 5、 Documents for future reference
1. Heren Health Co.Ltd(300550) 2021 annual general meeting resolution;
2. Legal opinion of Zhejiang Tiance law firm on the 2021 annual general meeting of shareholders of the company.
It is hereby announced.
Heren Health Co.Ltd(300550) board of directors may 18, 2022
